Eyenovia Inc (NASDAQ: EYEN) on Monday, plunged -5.09% from the previous trading day, before settling in for the closing price of $0.49. Within the past 52 weeks, EYEN’s price has moved between $0.37 and $2.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 100.00% over the past five years. The company achieved an average annual earnings per share of 4.88%. With a float of $75.94 million, this company’s outstanding shares have now reached $85.54 million.
Let’s look at the performance matrix of the company that is accounted for 57 employees. In terms of profitability, gross margin is -4363.73%, operating margin of -98956.52%, and the pretax margin is -118712.53%.
Eyenovia Inc (EYEN) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Eyenovia Inc is 11.22%, while institutional ownership is 13.81%. The most recent insider transaction that took place on Aug 28 ’24, was worth 14,077. In this transaction Chief Executive Officer of this company bought 27,071 shares at a rate of $0.52, taking the stock ownership to the 109,998 shares. Before that another transaction happened on Aug 26 ’24, when Company’s Chief Executive Officer bought 50,000 for $0.57, making the entire transaction worth $28,500. This insider now owns 82,927 shares in total.
Eyenovia Inc (EYEN) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.18 earnings per share (EPS) for the period topping the consensus outlook (set at -0.18) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.88% per share during the next fiscal year.
Eyenovia Inc (NASDAQ: EYEN) Trading Performance Indicators
Eyenovia Inc (EYEN) is currently performing well based on its current performance indicators. A quick ratio of 0.24 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1330.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Eyenovia Inc (EYEN)
Eyenovia Inc (NASDAQ: EYEN) saw its 5-day average volume 0.67 million, a negative change from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 8.76%. Additionally, its Average True Range was 0.04.
During the past 100 days, Eyenovia Inc’s (EYEN) raw stochastic average was set at 7.92%, which indicates a significant increase from 3.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.90% in the past 14 days, which was lower than the 119.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5056, while its 200-day Moving Average is $0.9229. Nevertheless, the first resistance level for the watch stands at $0.4811 in the near term. At $0.4981, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5086. If the price goes on to break the first support level at $0.4536, it is likely to go to the next support level at $0.4431. Assuming the price breaks the second support level, the third support level stands at $0.4261.
Eyenovia Inc (NASDAQ: EYEN) Key Stats
Market capitalization of the company is 39.91 million based on 64,059K outstanding shares. Right now, sales total 4 K and income totals -27,260 K. The company made 20 K in profit during its latest quarter, and -11,050 K in sales during its previous quarter.
